| Dr Mark Thomas Day, DO | |
|
525 N Santiam Hwy, Lebanon, OR 97355-4363 | |
| (541) 258-2101 | |
| Not Available |
| Full Name | Dr Mark Thomas Day |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 7 Years |
| Location | 525 N Santiam Hwy, Lebanon, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225492796 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Mount Hood Medical Center | Gresham, OR | Hospital |
| Legacy Salmon Creek Medical Center | Vancouver, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Clinics Llc | 0244144004 | 603 |
| Legacy Good Samaritan Hospital And Medical Center | 0547179939 | 128 |
| Legacy Mount Hood Medical Center | 3173515996 | 43 |
| Legacy Emanuel Hospital And Health Center | 4587573639 | 170 |
| Legacy Salmon Creek Hospital | 0446295711 | 223 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
| Entity Name | Legacy Good Samaritan Hospital And Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780608216 PECOS PAC ID: 0547179939 Enrollment ID: O20031125000416 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
| Entity Name | Legacy Emanuel Hospital & Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831112358 PECOS PAC ID: 4587573639 Enrollment ID: O20040127001204 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
| Entity Name | Legacy Mount Hood Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386919132 PECOS PAC ID: 3173515996 Enrollment ID: O20040401000550 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1801847066 PECOS PAC ID: 2466353529 Enrollment ID: O20061104000163 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Thomas Day, DO Po Box 1193, Corvallis, OR 97339-1193 Ph: (541) 768-4906 | Dr Mark Thomas Day, DO 525 N Santiam Hwy, Lebanon, OR 97355-4363 Ph: (541) 258-2101 |
News Archive
An analysis by The Associated Press points out that the GOP may be gelling around presidential hopeful Mitt Romney despite his role while governor in advancing the Massachusetts health law. Meanwhile, the AP also reports that rival candidate Rick Santorum offered his support for the budget plan announced this week by Rep. Paul Ryan, R-Wis., but said he would be more aggressive in achieving savings. Medicaid would be one of his targets.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.
› Verified 4 days ago
Dr. Robert D. Wimmer, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 525 N Santiam Hwy, Lebanon, OR 97355 Phone: 541-451-6427 Fax: 541-451-7520 | |
Cody Talbot, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Mullins Dr Ste C2, Lebanon, OR 97355 Phone: 541-451-6413 | |
Dr. Jourdan Leigh Hull, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 525 N Santiam Hwy, Lebanon, OR 97355 Phone: 541-451-6479 Fax: 541-451-7085 | |
Dr. Randy J. Mccoy, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 325 Park St, Lebanon, OR 97355 Phone: 541-451-7200 | |
Dr. Sedrick A. Salisbury, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 325 Park St, Lebanon, OR 97355 Phone: 541-451-7200 | |
Dr. Dana L. Kosmala, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 675 N 5th St Ste 200, Lebanon, OR 97355 Phone: 541-451-6282 |